Related references
Note: Only part of the references are listed.Renin-Angiotensin Blockade Combined With Natriuretic Peptide System Augmentation Novel Therapeutic Concepts to Combat Heart Failure
Thomas G. von Lueder et al.
CIRCULATION-HEART FAILURE (2013)
First-in-Class Angiotensin Receptor Neprilysin Inhibitor in Heart Failure
O. Vardeny et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics
Sarah Mangiafico et al.
EUROPEAN HEART JOURNAL (2013)
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
John J. V. McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial
Mihai Gheorghiade et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure
Karl Swedberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Karl Swedberg et al.
LANCET (2010)
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure.
Anthony S. L. Tang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure HF-ACTION Randomized Controlled Trial
Christopher M. O'Connor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
Marvin A. Konstam et al.
LANCET (2009)
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events.
Arthur J. Moss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema
R. M. Fryer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Rosuvastatin in older patients with systolic heart failure
John Kjekshus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM
Eldrin F. Lewis et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
The effect of cardiac resynchronization on morbidity and mortality in heart failure
JGF Cleland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Omapatrilat and enalapril in patients with hypertension: The omapatrilat cardiovascular treatment vs. enalapril (OCTAVE) trial
OB Kostis et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:: the CHARM-Added trial
JJV McMurray et al.
LANCET (2003)
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol, European Trial (COMET): randomised controlled trial
PA Poole-Wilson et al.
LANCET (2003)
Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure:: baseline characteristics of patients in the Candesartan in Heart failure -: Assessment of Reduction in Mortality and morbidity (CHARM) programme
J McMurray et al.
EUROPEAN JOURNAL OF HEART FAILURE (2003)
Comparison of omapatrilat chronic and enalapril in patients with heart failure - The omapatrilat versus enalapril randomized trial of utility in reducing events (OVERTURE)
M Packer et al.
CIRCULATION (2002)
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
JN Cohn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of carvedilol on survival in severe chronic heart failure.
M Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure -: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)
Å Hjalmarson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: A new health status measure for heart failure
CP Green et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Share Paper
